1. Mycoplasma pneumoniae among Chinese Outpatient Children with Mild Respiratory Tract Infections during the Coronavirus Disease 2019 Pandemic
- Author
-
Jiande Chen, Jing Zhang, Zhiwei Lu, Yu Chen, Songsong Huang, Hengtao Li, Shuzhu Lin, Jun Yu, Xueqi Zeng, Cuihong Ji, Yuejie Zheng, Fangfang Dai, Wei Dong, Huiting Xu, Weichao Chen, Xiaoqun Jin, Zhen Cui, Jing Qiao, Wei Qin, Hui Chen, Wei Jiang, Xiaoying Zhang, Jingrong Song, Jie Shao, Wen Su, Chao Wang, Fang Liu, Yuhua Zhao, Yingxue Zou, Run Guo, Lei Zhang, Jinhong Wu, Shuhua Yuan, Mingyu Tang, Yufen Wu, Jie Lin, Wenfang Dong, Xing Chen, Xinrong Sun, and Yong Yin
- Subjects
Microbiology (medical) ,Adult ,Male ,China ,Adolescent ,Physiology ,Young Adult ,Drug Resistance, Bacterial ,Outpatients ,Pneumonia, Mycoplasma ,Genetics ,Humans ,Prospective Studies ,Child ,Respiratory Tract Infections ,General Immunology and Microbiology ,Ecology ,COVID-19 ,Infant ,Cell Biology ,Anti-Bacterial Agents ,Mycoplasma pneumoniae ,Infectious Diseases ,Child, Preschool ,Female ,Macrolides - Abstract
Mycoplasma pneumoniae is a common pathogen causing respiratory disease in children. We sought to investigate the epidemiology of M. pneumoniae among outpatient children with mild respiratory tract infections (RTIs) during the coronavirus disease 2019 (COVID-19) pandemic. Eligible patients were prospectively enrolled from January 2020 to June 2021. Throat swabs were tested for M. pneumoniae RNA. M. pneumoniae IgM was tested by a colloidal gold assay. Macrolide resistance and the effect of the COVID-19 countermeasures on M. pneumoniae prevalence were assessed. Symptom scores, treatments, and outcomes were evaluated. Eight hundred sixty-two eligible children at 15 centers in China were enrolled. M. pneumoniae was detected in 78 (9.0%) patients. Seasonally, M. pneumoniae peaked in the first spring and dropped dramatically to extremely low levels over time until the next summer. Decreases in COVID-19 prevalence were significantly associated with decreases in M. pneumoniae prevalence (
- Published
- 2022